End-to-end solutions for multiomic research for bringing therapeutics to market faster

Azenta Life Sciences has expanded its current multiomics services to include Olink technology, which ensures robust, multiplex protein biomarker analysis of samples in a CAP/CLIA laboratory environment. Azenta has a global footprint offering an end-to-end solution, from sample procurement and storage to sample analysis, enabling biopharma companies to accelerate scientific research. The breadth of Azenta’s offerings allows for the discovery, storage, and monitoring of changes in clinical samples with Olink as well as RNA and DNA analysis.

The Value of Olink

With Olink, Azenta can leverage Proximity Extension Assay (PEA) technology coupled to a qPCR or NGS readout. This highly specific biomarker discovery platform requires only 1 µL of sample input for analysis, which means that extremely small sample volumes can measure large numbers of proteins simultaneously.

For more information about how this expanded support will bring additional value for the pharma industry, please visit our protein biomarker discovery solutions page or contact us to set up a time to speak with our subject matter experts.

Recent news from Azenta